BioregulatorsResearch profile

Chonluten

Glu-Asp-Gly · EDG · Bronchial epithelium bioregulator

Think of it as a tiny coach for your lung cells.

Chonluten works like a personal trainer for your lungs. It communicates with the cells lining your airways, encouraging them to repair and maintain themselves. Think of it as whispering tips to your lung cells on how to stay in top shape.

This peptide is still in the early stages of research, mostly from Russian studies, where it's been explored for its potential to support lung health, especially as we age. While it shows promise in helping lung tissue repair itself, it's not yet widely tested or approved outside of these studies.

Who it's for

Smokers or ex-smokers curious about lung health
Older adults interested in lung maintenance
Biohackers exploring cutting-edge peptides

Probably not for you if…

Anyone looking for FDA-approved treatments
Individuals with serious lung conditions needing immediate medical treatment
People who prefer well-established supplements over experimental ones

Editorial summary for research context · Not medical advice

Mechanism of Action

Chonluten is a synthetic tripeptide (Glu-Asp-Gly) designed as a bronchial-epithelium bioregulator. Khavinson-group research proposes that short peptides penetrate the cell membrane, enter the nucleus, and modulate tissue-specific gene expression — in this case in bronchial epithelial cells and alveolar tissue. Not FDA-approved. Preclinical and limited clinical data from Khavinson group.

Researched Benefits

Bronchial epithelium gene modulation

Khavinson-lab cell-culture studies report modulation of gene expression relevant to bronchial epithelial differentiation and mucosal repair.

[Khavinson & Kuznik 2012]

Preclinical pulmonary aging research

Russian-language studies have examined lung morphology endpoints in aged rodent models.

[Chalisova et al. 2014]

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

Intranasal research protocol

Dosage: 100 mcg
Frequency: once daily
Timing: morning
Cycle: 3 weeks

Khavinson-group protocols have typically used 20-30 day cycles.

Reported Side Effects

No significant adverse events reported in published Khavinson-group studies
Transient local irritation with intranasal administration
Long-term human safety data limited

Contraindications

Pregnancy and lactation (no safety data)
Active pulmonary malignancy (theoretical concern)
Individual hypersensitivity to peptide components

Stacking Partners

Peptides commonly paired with Chonluten in published research and protocol write-ups.

bioregulator

Vendor Pricing

75
Swiss Chems
Best $/mg
Size20mg
Total$58.99
/ mg$2.95/mg
In stock
View

Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.

Research Papers

Peptides as regulators of gene expression
Khavinson VKh, Kuznik BI · Advances in Gerontology · 2012

Chonluten

Mechanism of Action